Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?
Sneller
Michael C
MC
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab